Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
…, KJ Seung,K Schnippel, TS Shim, RSingla… - The Lancet, 2018 - Elsevier
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …
to estimate the association of treatment success and death with the use of individual drugs, …
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
…, GF Schecter, TS Shim, RSingla… - European …, 2012 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
…,P Nahid, D Rodrigues, RSingla… - The Lancet Respiratory …, 2020 - Elsevier
Background Treatment of multidrug-resistant tuberculosis requires long-term therapy with a
combination of multiple second-line drugs. These drugs are associated with numerous …
combination of multiple second-line drugs. These drugs are associated with numerous …
A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis
…, N Malhotra, JA Caminero, RSingla… - European …, 2020 - Eur Respiratory Soc
Both tuberculosis and COVID-19 being communicable and prevalent diseases in India, the
co-existence can lead to worse outcomes, as seen in this study, where there was high …
co-existence can lead to worse outcomes, as seen in this study, where there was high …
Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects
Development of noninvasive methods for tuberculosis (TB) diagnosis, with the potential to be
administered in field situations, remains as an unmet challenge. A wide array of molecules …
administered in field situations, remains as an unmet challenge. A wide array of molecules …
Does diabetes alter the radiological presentation of pulmonary tuberculosis.
MA Shaikh, RSingla,NB Khan, NS Sharif… - Saudi medical …, 2003 - europepmc.org
OBJECTIVE: The aim of this study is to determine whether diabetes mellitus (DM) alters the
radiological manifestations of pulmonary tuberculosis (TB). METHODS: A retrospective …
radiological manifestations of pulmonary tuberculosis (TB). METHODS: A retrospective …
[HTML][HTML]Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations
…, N Shafiq,N Sharma, UPS Sidhu, RSingla… - Lung India: Official …, 2015 - ncbi.nlm.nih.gov
Asthma is defined as a chronic inflammatory disorder of the airways which manifests itself
as recurrent episodes of wheezing, breathlessness, chest tightness and cough. It is …
as recurrent episodes of wheezing, breathlessness, chest tightness and cough. It is …
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
…, V Schwoebel, W Sikhondze, RSingla… - European …, 2020 - Eur Respiratory Soc
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India
RSingla, JA Caminero, A Jaiswal… - European …, 2012 - Eur Respiratory Soc
Linezolid is identified as an effective drug with which to treat patients failing multidrug-resistant
(MDR)-tuberculosis (TB) treatment. However, cost and safety are the concerns. In India, …
(MDR)-tuberculosis (TB) treatment. However, cost and safety are the concerns. In India, …
[HTML][HTML]Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region
…, N Makkar, JN Banavaliker, M Hanif, RSingla… - PLoS …, 2013 - journals.plos.org
Background India with a major burden of multidrug-resistant tuberculosis (MDR-TB) does not
have national level data on this hazardous disease. Since 2006, emergence of extensively …
have national level data on this hazardous disease. Since 2006, emergence of extensively …